| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.14 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |